Propeller Health, the
FDA-cleared digital health solution for chronic respiratory disease, announced that it raised $14.5 million in Series B financing, led
by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor The Social+Capital Partnership.
Propeller Health will use the funding to accelerate product
development, strategic alliances, client services, sales and marketing.

Read the full release here.